Jan Hedner, MD, PhD: Current Therapeutic Landscape of Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is a space that’s been lacking treatment options for quite a while, however, in the last year or so, promising research has identified different novel pathophysiological mechanisms that could potentially serve to subclassify various phenotypes in sleep apnea. The identification of these subtypes could offer novel strategies in drug development that may lead to new and effective therapies targeting more specific mechanisms to treat sleep apnea.

To provide more insight on the current landscape of pharmacological therapies for obstructive sleep apnea, NeurologyLive spoke with Jan Hedner, MD, PhD, professor of sleep medicine, family medicine, Sahlgrenska University Hospital, Gotenburg, at the Congress of the European Sleep Research Society in Basel, Switzerland.

[perlaursen]

This is very promising...thanks Dr Hedner. Per L in Denmark